Evaluation of the Impact of Optical Coherence Tomography on Pediatrician Otologic Examination Judgment

Teague, Malinda S.; Nolan, Ryan M.

doi:10.1002/oto2.41

Cited by 2 publications

(2 citation statements)

References 20 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The OtoSight Middle Ear Scope (PhotoniCare) is a video otoscope which allows for direct visualization of the tympanic membrane with optical coherence tomography. The technology also allows physicians to view beyond the tympanic membrane to assess for middle ear pathology 4 . It uses low‐coherence light to capture 2D and 3‐dimensional (3D) images of the middle ear tissue.…”

Section: Discussionmentioning

confidence: 99%

“…The technology also allows physicians to view beyond the tympanic membrane to assess for middle ear pathology. 4 It uses low‐coherence light to capture 2D and 3‐dimensional (3D) images of the middle ear tissue. The technology allows clinicians to visualize past cerumen, other canal obstructions, and opacified tympanic membranes to guide the clinician in evaluating middle ear disease.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

Wu,

Gorelik,

Brenner

et al. 2024

OTO Open

View full text Add to dashboard Cite

ObjectiveTo review new drugs and devices relevant to otolaryngology approved by the Food and Drug Administration (FDA) in 2022.Data SourcesPublicly available FDA data on drugs and devices approved in 2022.Review MethodsA preliminary screen was conducted to identify drugs and devices relevant to otolaryngology. A secondary screen by members of the American Academy of Otolaryngology–Head and Neck Surgery's (AAO‐HNS) Medical Devices and Drugs Committee differentiated between minor updates and new approvals. The final list of drugs and devices was sent to members of each subspecialty for review and analysis.ConclusionA total of 1251 devices and 37 drugs were identified on preliminary screening. Of these, 329 devices and 5 drugs were sent to subspecialists for further review, from which 37 devices and 2 novel drugs were selected for further analysis. The newly approved devices spanned all subspecialties within otolaryngology. Many of the newly approved devices aimed to enhance patient experience, including over‐the‐counter hearing aids, sleep monitoring devices, and refined CPAP devices. Other advances aimed to improve surgical access, convenience, or comfort in the operating room and clinic.Implications for PracticeMany new devices and drugs are approved each year to improve patient care and care delivery. By staying up to date with these advances, otolaryngologists can leverage new innovations to improve the safety and quality of care. Given the recent approval of these devices, further studies are needed to assess long‐term impact within the field of otolaryngology.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

Wu,

Gorelik,

Brenner

et al. 2024

OTO Open

View full text Add to dashboard Cite

show abstract

Fusion of middle ear optical coherence tomography and computed tomography in three ears

Wang,

Couvreur,

Farrell

et al. 2024

Preprint

View full text Add to dashboard Cite

Importance: Middle ear OCT imaging in patients has not previously been directly compared to a standard of care clinical 3D imaging technology such as CT. This represents the first such comparison and provides new insight into OCT's capabilities, strengths and limitations. Objective: To qualitatively compare the capabilities of middle ear OCT to CT in normal and pathological ears on representative slices in co-registered OCT and CT datasets. Design, Setting, and Participants: One normal middle ear, one ear affected by traumatic injury and one ear with cholesteatoma were imaged with both OCT and high-resolution clinical temporal bone CT. Participants were drawn from the patient population of a tertiary otology clinic. CT and OCT images were aligned using rigid co-registration with manual landmark selection. Main Outcomes and Measures: Images were analyzed qualitatively for field of view, resolution, shadowing, artefacts, soft tissue and bony tissue contrast and presentation of diagnostically important features. Results: In the three imaged ears, OCT was capable of visualizing many of the important features indicative of middle ear pathology. When compared to CT, OCT was found to exhibit a limited field of view (FOV) largely confined to the mesotympanum and subject to shadowing from bony structures. However, OCT could resolve soft tissue features that were not readily apparent in the CT images, to have a higher resolution than CT and to provide excellent anatomical fidelity with CT which allowed OCT images to be accurately co-registered with CT images. Conclusions and Relevance: The results support a role for middle ear OCT in otological diagnostics. While OCT is not capable of replacing CT due to its limited FOV and inability to image through thick bony tissues, it can visualize many signs of pathology including some soft tissue features that are difficult to visualize with CT. Given OCT's ability to image in real-time, its compatibility with in-office imaging and its lack of ionizing radiation, it may, despite its limitations compared to CT, be an appealing imaging modality for many applications in middle ear diagnostics.

show abstract

Evaluation of the Impact of Optical Coherence Tomography on Pediatrician Otologic Examination Judgment

Cited by 2 publications

References 20 publications

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

Fusion of middle ear optical coherence tomography and computed tomography in three ears

Contact Info

Product

Resources

About